Clinical Research Associates of Tidewater   Report issue

For profit Phase 3
Founded: Norfolk VA United States (1974)
Status: Acquired by Alliance for Multispecialty Research (2017)

Organization Overview

First Clinical Trial
2011
NCT01268618
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (3)

bifidobacterium bifidum (1 trial)

chickpea (1 trial)

lactobacillus delbrueckii (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 3)

Dyspepsia (Phase 3)

Gastrointestinal Diseases (Phase 3)

Irritable Bowel Syndrome (Phase 3)

Signs and Symptoms, Digestive (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3